neo recormon 5000 iu injection - Recombinant Human Erythropoietin Beta (5000IU) medicine

Neo Recormon 5000 Iu Injection: Complete Medicine Guide

No reviews yet
🏭 Roche Products India Pvt Ltd 📦 Varies by brand 💊 Allopathy 📅 Updated: Nov 1, 2026
📋 Prescription Required 💊 Generic Available
Medically Reviewed
11 min read
Evidence: Well-established for approved indications.
Reviewed by
SaathiMed Expert Panel | Nov 01, 2026
🩺
Medically Fact-Checked & Clinically Verified by SaathiMed Clinical Review Board
Clinical Reference Standards: CDSCO (Central Drugs Standard Control Organisation), Indian Pharmacopoeia (IP) & WHO | Last Updated: September 2026

When to Call Your Doctor IMMEDIATELY

  • Severe headache with blurred vision or confusion
  • Chest pain, shortness of breath, or difficulty breathing
  • Sudden swelling, pain, or redness in an arm or leg
  • Seizures or loss of consciousness
  • Signs of allergic reaction: rash, itching, swelling of face or throat
  • Unusual fatigue or paleness despite treatment
  • Decreased urine output or swelling in legs

If experiencing severe symptoms, call emergency services immediately.

What is neo recormon 5000 iu injection used for?

This medicine is a recombinant human erythropoietin beta injection used to treat anaemia in chronic kidney disease, chemotherapy, and surgery. It stimulates red blood cell production. It is given by injection under medical supervision.

  • Generic Name: Recombinant Human Erythropoietin Beta (5000IU)
  • Manufacturer: Roche Products India Pvt Ltd
  • Form: Allopathy
  • Pregnancy Category: Consult doctor
  • Prescription Required: Yes

🇮🇳 neo recormon 5000 iu injection के बारे में (Hindi Summary)

उपयोग: यह दवा रिकॉम्बिनेंट ह्यूमन एरिथ्रोपोइटिन बीटा का इंजेक्शन है, जिसका उपयोग गुर्दे की बीमारी, कैंसर कीमोथेरेपी और सर्जरी से जुड़े एनीमिया (खून की कमी) के इलाज में किया जाता है। यह शरीर में लाल रक्त कोशिकाओं का उत्पादन बढ़ाकर हीमोग्लोबिन के स्तर को सुधारती है। यह दवा केवल डॉक्टर की देखरेख में इंजेक्शन के रूप में दी जाती है।

साइड इफेक्ट्स: आम दुष्प्रभावों में उच्च रक्तचाप, सिरदर्द, इंजेक्शन स्थल पर दर्द और फ्लू जैसे लक्षण शामिल हैं। गंभीर दुष्प्रभावों में गंभीर उच्च रक्तचाप, दौरे, रक्त के थक्के और शुद्ध लाल कोशिका अप्लासिया हो सकते हैं। किसी भी असामान्य लक्षण को तुरंत डॉक्टर को बताएं।

सुरक्षा सलाह: यह दवा केवल योग्य स्वास्थ्य पेशेवर द्वारा ही दी जानी चाहिए। नियमित रूप से रक्तचाप, हीमोग्लोबिन और आयरन की जांच करवाएं। खुद से इंजेक्शन न लगाएं। यदि आपको चक्कर आते हैं या दृष्टि में बदलाव होता है तो वाहन न चलाएं। सभी जांचों के लिए समय पर जाएं। दवा को निर्देशानुसार स्टोर करें।

💡 Did You Know? India is the largest provider of generic medicines globally, supplying over 50% of global vaccine demand.

💊 neo recormon 5000 iu injection Uses & Benefits

[{"condition":"Anaemia of chronic kidney disease","description":"This medicine stimulates red blood cell production in patients with chronic kidney disease who are not on dialysis or are on dialysis, reducing the need for blood transfusions.","evidence":"Well-established"},{"condition":"Chemotherapy-induced anaemia","description":"Used to treat anaemia in cancer patients receiving myelosuppressive chemotherapy, reducing transfusion requirements.","evidence":"Well-established"},{"condition":"Anaemia in patients undergoing major surgery","description":"Administered to reduce the need for allogeneic blood transfusions in patients scheduled for major elective surgery.","evidence":"Well-established"},{"condition":"Anaemia associated with chronic diseases","description":"May be used in select patients with anaemia due to chronic inflammatory conditions, though use is individualized.","evidence":"Moderate"}]

Off-label uses: [{"condition":"Anaemia in myelodysplastic syndromes","description":"Sometimes prescribed off-label to manage anaemia in low-risk myelodysplastic syndromes.","evidence":"Limited"},{"condition":"Anaemia in HIV patients on zidovudine","description":"May be used off-label to treat anaemia in HIV-positive patients receiving zidovudine therapy.","evidence":"Limited"}]

Primary treatment for: Anaemia

Also treats: Chronic kidney disease, Cancer, Chronic inflammatory conditions

📋 Drug Information

Generic Name(s)Recombinant Human Erythropoietin Beta (5000IU)
Brand Nameneo recormon 5000 iu injection
ManufacturerRoche Products India Pvt Ltd
Packaging / FormVaries by brand (Allopathy)
Therapeutic ClassBLOOD RELATED
Action ClassErythropoiesis-stimulating agent (ESA)
Route of AdministrationParenteral (subcutaneous or intravenous injection)
StorageStore refrigerated at 2°C to 8°C. Do not freeze. Keep the container in the outer carton to protect from light. Do not shake.
Shelf LifeRefer to the product packaging for the expiry date. Typically 2 years from the date of manufacture when stored properly.
WHO GuidelineNot established from the available information.
ICMR GuidelineNot established from the available information.

👨‍⚕️ Doctor's Practical Tips

Evidence-based practical advice from experienced clinicians

1
Always check blood pressure before administering this medicine; uncontrolled hypertension is a contraindication.
2
Ensure adequate iron stores before initiating therapy; iron deficiency can reduce efficacy.
3
Monitor haemoglobin levels regularly and avoid overcorrection beyond the target range.
4
Rotate injection sites to minimize local reactions.
5
Educate patients about the signs of thromboembolism and when to seek immediate care.
6
Use the lowest effective dose to minimize cardiovascular risks.
7
In cancer patients, weigh the benefits against the risk of tumour progression.

🔍 Is This Medicine Right for Your Symptom?

Educational reference. Always consult a doctor for diagnosis.

✅
Fatigue and weakness
This medicine is used to treat anaemia, which causes fatigue.
Likely Use
✅
Shortness of breath
Anaemia can cause shortness of breath; this medicine may help.
Likely Use
❌
Fever
This medicine is not a primary fever reducer.
Not Primary

🔬 How This Medicine Works (Pharmacology)

Pharmacokinetics

AbsorptionFollowing subcutaneous administration, recombinant human erythropoietin beta is absorbed slowly, with peak plasma concentrations occurring 12-18 hours after injection. The bioavailability is approximately 20-30% for subcutaneous route. Intravenous administration results in immediate peak levels but shorter duration.
DistributionThe volume of distribution is approximately 0.05-0.1 L/kg. It is distributed primarily in the plasma and extracellular fluid. It does not cross the blood-brain barrier significantly.
Protein BindingNot established from the available information.
MetabolismThe metabolism of recombinant human erythropoietin beta is not fully characterized. It is believed to be degraded by general protein catabolism in the body.
Half-LifeThe elimination half-life is approximately 24 hours after subcutaneous administration and 4-13 hours after intravenous administration in patients with chronic kidney disease.
ExcretionExcretion pathways are not fully established. It is likely eliminated via protein catabolism and possibly renal excretion.
BioavailabilitySubcutaneous bioavailability is approximately 20-30%.
Onset of ActionReticulocyte count increases within 3-4 days; haemoglobin rise is typically seen within 2-6 weeks.
Peak Plasma Time12-18 hours after subcutaneous injection.
Duration of ActionThe effect on erythropoiesis lasts for several days to weeks, depending on the dose and patient factors.

How It Works

Recombinant human erythropoietin beta binds to erythropoietin receptors on the surface of erythroid progenitor cells in the bone marrow. This binding activates JAK2/STAT5 signalling pathways, leading to increased proliferation, differentiation, and survival of red blood cell precursors. The result is an increase in reticulocyte count and ultimately haemoglobin levels.

Mechanism Steps

1
Binding to erythropoietin receptor: This medicine binds specifically to erythropoietin receptors on erythroid progenitor cells.
2
Receptor dimerization and activation: Binding induces receptor dimerization, activating associated JAK2 kinases.
3
JAK2/STAT5 signalling: Activated JAK2 phosphorylates STAT5, which translocates to the nucleus and promotes gene expression.
4
Increased erythropoiesis: This leads to proliferation, differentiation, and survival of erythroid precursor cells, increasing red blood cell production.

💡 How to Take neo recormon 5000 iu injection

Strength: 5000 IU injection

1This medicine is administered by a healthcare professional as an injection.
2It can be given subcutaneously (under the skin) or intravenously (into a vein).
3Do not self-administer unless trained to do so.
4Follow your doctor's instructions regarding dose and frequency.
5Rotate injection sites to prevent irritation.
6Do not shake the vial; gently swirl if needed.
7Inspect the solution before use; do not use if particles are present or if discoloured.

Dosage Information

Adult DosageThe dose of this medicine must be individualized by a qualified clinician based on the indication, patient's age, weight, renal and hepatic function, and response to therapy. For anaemia of chronic kidney disease, a typical starting dose is 50-100 IU/kg three times per week subcutaneously or intravenously. For chemotherapy-induced anaemia, a starting dose of 150 IU/kg three times per week or 450 IU/kg once weekly subcutaneously is common. For surgery, 300 IU/kg/day for 10 days before surgery, on the day of surgery, and for 4 days after. Always follow your doctor's prescription.
Pediatric DosagePediatric dosing is not established from available information. Consult a pediatrician.
Elderly DosageElderly patients may be more sensitive to the effects of this medicine. Dose selection should be cautious, and monitoring of blood pressure and haemoglobin is essential. No specific dose adjustment is established solely based on age; individualization by a clinician is required.
Renal ImpairmentIn patients with chronic kidney disease, the dose is individualized based on haemoglobin levels and clinical response. Lower doses may be appropriate. Regular monitoring of renal function and haemoglobin is necessary.
Hepatic ImpairmentNo specific dose adjustment is established for hepatic impairment. Use with caution and monitor closely.
Maximum Daily DoseThe maximum dose should not exceed the dose prescribed by your doctor. Typically, doses above 300 IU/kg three times per week are not recommended. Individualization is essential.

Dosage Timeline

🌅 Morning ❌ ☀️ Afternoon ❌ 🌆 Evening ❌ 🌙 Night ❌

⏰ What to Do If You Miss a Dose

📌 Less than half the dosing interval has passed
→ Take the missed dose as soon as you remember.
💡 Continue with the regular schedule.
📌 More than half the dosing interval has passed
→ Skip the missed dose.
💡 Do not double dose to catch up.

⚠️ Side Effects of neo recormon 5000 iu injection

✅ Common Side Effects

Hypertension (Common (10-20%))
Monitor blood pressure regularly. If elevated, consult your doctor for adjustment of antihypertensive therapy.
Headache (Common (5-15%))
Usually resolves on its own. If persistent or severe, consult your doctor.
Injection site pain (Common (5-10%))
Apply a cold compress. Rotate injection sites. Consult doctor if pain persists.
Flu-like symptoms (Common (5-10%))
Rest and stay hydrated. Consult doctor if symptoms worsen.

🚨 Serious Side Effects

Hypertensive crisis (Rare (<1%))
Seek immediate medical attention if you experience severe headache, blurred vision, or chest pain.
Seizures (Rare (<1%))
Call emergency services if seizures occur.
Thromboembolic events (Uncommon (1-5%))
Seek immediate care if you notice swelling, pain, or redness in limbs, or difficulty breathing.
Pure red cell aplasia (Very rare (<0.1%))
Report sudden severe anaemia or lack of response to therapy to your doctor immediately.

⚠️ Rare Side Effects

Allergic reactions
Seek emergency care if you experience rash, itching, swelling, or difficulty breathing.
Hyperkalaemia
Regular blood tests are needed. Report muscle weakness or irregular heartbeat.

Consult your doctor if you experience any unusual symptoms.

🔬 Drug Interactions

Drug Severity Effect
Antihypertensives Major
Hormonal contraceptives Major
Iron supplements Moderate
ACE inhibitors Moderate
Ciclosporin Minor

🚨 Major Interactions

  • Antihypertensives
  • Drugs that increase thrombosis risk (e.g., hormonal contraceptives)

⚡ Moderate Interactions

  • Iron supplements
  • Angiotensin-converting enzyme inhibitors

🍷 Alcohol Interaction

Alcohol may increase blood pressure and worsen anaemia; it is advisable to avoid or limit alcohol consumption while on this medicine.

🔎 Check Your Other Medicines

Educational tool. Always confirm with your doctor or pharmacist.

🛡️ Safety & Warnings

🚫 Contraindications

["Uncontrolled hypertension","Hypersensitivity to recombinant human erythropoietin beta or any excipient","Pure red cell aplasia","Use in patients with certain cancers where ESAs may worsen outcomes","Severe cardiovascular disease (relative)"]

⚠️ Warnings & Precautions

["Monitor blood pressure closely; hypertension may occur or worsen.","Ensure adequate iron stores before and during therapy.","Risk of thromboembolic events; use lowest effective dose.","May cause seizures, especially in patients with a history.","Do not use in patients with uncontrolled hypertension.","Haemoglobin should be monitored regularly; avoid overcorrection.","In cancer patients, ESAs may increase the risk of tumour progression or mortality; use with caution.","Injection site reactions may occur; rotate sites.","Use with caution in patients with a history of seizures or cardiovascular disease.","Not for use in patients with pure red cell aplasia."]

🤱 Lactation Safety

It is not known whether recombinant human erythropoietin beta is excreted in human milk. Caution should be exercised when administered to a nursing woman. Consult your doctor.

💊 Overdose Management

Overdose may lead to excessive erythropoiesis, resulting in dangerously high haemoglobin levels and increased risk of thromboembolic events. Treatment is symptomatic and supportive. In case of overdose, seek immediate medical attention. Haemoglobin levels should be monitored, and phlebotomy may be considered if necessary.

⏰ Missed Dose

If you miss a dose, contact your healthcare provider for guidance. Do not double the dose to catch up. The dosing schedule should be individualized by your doctor.

Additional Safety Advice

General Safety

This medicine must only be administered under the supervision of a qualified healthcare professional. Regular monitoring of blood pressure, haemoglobin, and iron levels is essential. Do not self-administer. Inform your doctor if you have a history of hypertension, seizures, or blood clots. Avoid driving or operating heavy machinery if you experience dizziness or visual disturbances. Keep all appointments for blood tests. Do not share this medicine with others. Store as directed and check the expiry date before use.

👴 Special Considerations for Elderly

💡 For Patients Above 65

Elderly patients may be more susceptible to hypertension and cardiovascular events. Close monitoring of blood pressure and haemoglobin is recommended. Dose adjustment may be necessary based on renal function.

🤰 Pregnancy Planning (TTC)

If you are planning pregnancy, consult your doctor. The safety of this medicine during pregnancy is not well established. Use effective contraception if advised.

🏥 Post-Surgery Considerations

This medicine may be used before and after surgery to reduce transfusion needs. Follow your doctor's instructions regarding dosing and monitoring.

🦷 Dental Procedures

Inform your dentist about this medicine. No specific precautions are established, but maintain good oral hygiene.

💚 Lifestyle Tips for Better Results

🏃
Maintain a healthy blood pressure through diet and exercise.
🥗
Ensure adequate iron intake through diet or supplements as advised.
😴
Stay hydrated.
💧
Avoid smoking, which can worsen cardiovascular risk.
🧘
Follow a balanced diet rich in vitamins and minerals.
🌞
Get regular check-ups and blood tests.

🏋️ Exercise Considerations

Moderate exercise is generally safe, but avoid strenuous activity if you have severe anaemia or cardiovascular disease. Consult your doctor before starting any exercise program.

🥗 Diet Recommendations

Include iron-rich foods like lean meat, beans, and leafy greens.
Ensure adequate vitamin B12 and folate intake.
Limit alcohol consumption.
Reduce sodium intake to manage blood pressure.

💼 Impact on Daily Work & Life

This medicine may cause dizziness or visual disturbances in some patients. Avoid driving or operating heavy machinery until you know how it affects you. Most patients can continue their daily activities, but fatigue may limit strenuous work.

🛑 When to Stop This Medicine

Do not stop this medicine without consulting your doctor. Stopping abruptly may lead to worsening anaemia. Your doctor will determine when to stop based on your haemoglobin levels and clinical condition.

📅 Long-Term Use Effects

Long-term use may increase the risk of cardiovascular events, thromboembolism, and hypertension. Regular monitoring of haemoglobin, blood pressure, and iron status is essential. Overcorrection of haemoglobin should be avoided. In cancer patients, long-term use may be associated with tumour progression. Periodic review of the risk-benefit ratio is necessary.

🌿 Non-Medicine Approaches

These can complement medicine but do not replace prescribed treatment.

Iron supplementation

If iron deficiency is the cause of anaemia, iron supplements may be used.

Evidence: Well-established
Blood transfusion

For severe anaemia, blood transfusion may be necessary.

Evidence: Well-established

💉 Vaccination Considerations

💉 If You're Getting Vaccinated

No specific vaccine interactions are established. However, consult your doctor before receiving any live vaccines while on this medicine.

📦 Storage Guide

✅ DO

Store refrigerated at 2°C to 8°C

❌ DON'T

Do not freeze

✅ DO

Keep in original carton to protect from light

❌ DON'T

Do not shake the vial

✅ DO

Check expiry date before use

❌ DON'T

Do not use if solution is discoloured or contains particles

✈️ Traveling with This Medicine

Carry this medicine in its original packaging with a copy of your prescription. Store it in a refrigerated bag during travel. Inform airport security about the medication and any needles. Check customs regulations for carrying injectable medicines. Plan for time zone changes if on a scheduled dose; consult your doctor for adjustments.

💰 Cost Analysis & Savings

👥 Real Patient Stories

Educational, anonymized scenarios. Individual results may vary.

👤 A 58-year-old man with chronic kidney disease on dialysis
He was started on this medicine for anaemia. After 4 weeks, his haemoglobin improved from 8.5 to 10.5 g/dL, and he felt less fatigued. He required adjustment of his antihypertensive medication due to increased blood pressure. He learned to monitor his blood pressure at home and report any changes.
💡 Lesson: Regular monitoring of blood pressure and haemoglobin is crucial for safe and effective treatment.
👤 A 45-year-old woman undergoing chemotherapy for breast cancer
She received this medicine to manage chemotherapy-induced anaemia. Her energy levels improved, and she needed fewer blood transfusions. She experienced mild injection site pain, which was managed by rotating sites. She was advised to report any signs of blood clots.
💡 Lesson: This medicine can reduce transfusion needs but requires vigilance for thromboembolic events.

💬 Questions Patients Often Ask

Q: How long does it take to work?

A: Reticulocyte count increases within 3-4 days, but haemoglobin levels typically rise over 2-6 weeks. Regular monitoring is required.

Q: Can I self-administer this injection?

A: Only if you have been trained by a healthcare professional. Otherwise, it should be administered by a doctor or nurse.

Q: What should I do if I miss a dose?

A: Contact your healthcare provider for guidance. Do not double the dose.

Q: Is it safe during pregnancy?

A: Consult your doctor. The safety in pregnancy is not well established; use only if clearly needed.

🤔 Common Patient Concerns

💭 These are the concerns patients most commonly raise

  • Can I take this medicine long-term?
  • Will it affect my kidney function?
  • Can I drive after taking this medicine?
  • Does it interact with my blood pressure medicine?
  • What if I miss a dose?
  • Can I drink alcohol while taking this?

🛑 Myths vs. Facts

  • Myth: This medicine can be self-administered without training.
    Fact: This medicine must be administered by a healthcare professional or a trained caregiver.
  • Myth: More dose means faster recovery.
    Fact: Higher doses can increase the risk of serious side effects; the dose must be individualized.
  • Myth: This medicine is a blood transfusion substitute.
    Fact: It stimulates red blood cell production but is not a substitute for emergency blood transfusion.

🔄 Alternative Options

Brand Alternatives

📊 Comparison with Similar Medicines

[{"medicine":"Recombinant human erythropoietin beta","class":"Erythropoiesis-stimulating agent","half_life":"~24 hours (SC)","route":"Parenteral"},{"medicine":"Epoetin alfa","class":"Erythropoiesis-stimulating agent","half_life":"~24 hours (SC)","route":"Parenteral"},{"medicine":"Darbepoetin alfa","class":"Erythropoiesis-stimulating agent","half_life":"~49 hours (SC)","route":"Parenteral"}]

😊 Was this information helpful?

Browse Medicines A-Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Back to Medicines Directory